Pajjiż: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
propranolol hydrochloride, Quantity: 10 mg
Alphapharm Pty Ltd
Propranolol hydrochloride
Tablet
Excipient Ingredients: povidone; maize starch; lactose monohydrate; quinoline yellow; sunset yellow FCF aluminium lake; magnesium stearate; sodium starch glycollate
Oral
100
(S4) Prescription Only Medicine
Angina pectoris; Hypertension; Prevention of migraine; Cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline (epinephrine) overdosage); Essential tremor, including familial and senile tremor; Phaeochromocytoma (only with concurrent alpha-receptor blockade); Hypertrophic subaortic stenosis; Suspected or definite myocardial infarction; Fallot?s Tetralogy
Visual Identification: Orange coloured, round, biconvex tablets, embossed with "P" and "10" on either side of the breakline on one side and plain on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2015-02-13